Buscar
01/01/2026
The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI
Talmor-Barkan, Y, Levi, A, Barbanti, M, Valvo, R, Costa, G, Frittitta, V, De Backer, O, Willemen, Y, van den Dorpel, M, Mon, M, Sugiura, A, Sudo, M, Masiero, G, Pancaldi, E, Arzamendi, D, Garcia-Gomez, M, Baz, JA, Shapira, Y, Steblovnik, K, Mauri, V, Adam, M, Wienemann, H, Zahler, D, Hein, M, Ruile, P, Aodha, BN, Grasso, C, Branca, L, Estevez-Loureiro, R, Amat-Santos, IJ, Mylotte, D, Bunc, M, Tarantini, G, Nombela-Franco, L, Sondergaard, L, Van Mieghem, NM, Finkelstein, A, Kornowski, R, Witberg, G. The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI. INTERNATIONAL JOURNAL OF CARDIOLOGY. 2026; 442DOI:10.1016/j.ijcard.2025.133916. PMID:40976357. IF:3.200(Q2/3D).
01/10/2025
Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial
Bernal-Labrador, E, Romaguera, R, Garcia-Blas, S, Regueiro, A, Serra, V, Asmarats, L, Tizon-Marcos, H, Agudelo, V, Scardino, C, Casanova-Sandoval, JM, Rodríguez-Gabella, T, Jiménez-Méndez, C, Pérez-Rivera, A, Robles-Gamboa, C, Ayesta, A, Díez-Villanueva, P, Raposeiras-Roubín, S, Amat-Santos, IJ, Esteve-Pastor, A, Veiga-Fernández, G, Anguita, M, Martí-Sánchez, D, Martínez-Velilla, N, Cortés, L, Calvo, E, Asimbaya, S, Formiga, F, Ariza-Solé, A. Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trial. REC, interventional cardiology. 2025; 7(4)DOI:10.24875/RECIC.M25000522. PMID:41333125. IF:(Q/D).
01/02/2026
Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients
Esteban-Fernández, A, Bonilla-Palomas, JL, Muñiz, J, González-Manzanares, R, Anguita-Gámez, M, Recio-Mayoral, A, Mirabet, S, Cequier, A, García-Orta, R, Anguita-Sánchez, M. Age-based analysis of the SEC-Excelente-HF registry: clinical characteristics and prognosis of a prospective cohort of heart failure patients. European Geriatric Medicine. 2026; 17(1)DOI:10.1007/s41999-025-01392-9. PMID:41442098. IF:3.600(Q2/4D).
01/02/2026
Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis
Bagudá, JD, Sánchez, AS, de la Espriella, R, Valero-Masa, MJ, García-Vega, D, Ferrer, MD, de la Cal, TS, Mollar, A, Carmena, MDGC, Martínez-Dolz, L, de la Cruz, J, González-Juanatey, JR, Martínez-Sellés, M, Núñez, J, Jiménez, JFD. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis. HEART. 2026; 112(4)DOI:10.1136/heartjnl-2025-326053. PMID:40877030. IF:4.400(Q1/3D).
01/02/2026
Local modifications in tissular conditions before PFA increases acute lesion size
Amorós-Figueras, G, Casabella-Ramón, S, Moreno-Weidmann, Z, Castellvi, Q, Ivorra, A, García-Sánchez, T, Guerra, JM. Local modifications in tissular conditions before PFA increases acute lesion size. Heart Rhythm O2. 2026; 7(2)DOI:10.1016/j.hroo.2025.11.021. PMID:41732247. IF:(Q/D).
12/08/2025
Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin
Garcia-Arguinzonis, M, Escate, R, Lugano, R, Peña, E, Borrell-Pages, M, Badimon, L, Padro, T. Gene Expression Pattern Associated with Cytoskeletal Remodeling in Lipid-Loaded Human Vascular Smooth Muscle Cells: Crosstalk Between C3 Complement and the Focal Adhesion Protein Paxillin. Cells. 2025; 14(16)DOI:10.3390/cells14161245. PMID:40862724. IF:5.200(Q2/3D).
29/09/2025
Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study
Santisteban, V, López-Yerena, A, Muñoz-Garcia, N, Vilahur, G, Badimon, L, Padro, T. Obesity alters VLDL profile and remnant cholesterol differently in metabolically healthy men and women: a 1H-NMR study. Lipids in Health and Disease. 2025; 24(1)DOI:10.1186/s12944-025-02723-2. PMID:41024030. IF:4.200(Q1/3D).
22/01/2026
HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C
Padro, T, Muñoz-García, N, Fanlo-Maresma, M, Esteve-Luque, V, Cabré-Fernandez, P, Vilahur, G, Riera-Mestre, A, Badimon, L, Pinto, X. HDL function and composition in atherothrombotic cardiovascular disease with very high HDL-C. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2026; 56(1)DOI:10.1111/eci.70159. PMID:41413729. IF:3.600(Q1/2D).